Dr Christopher J C Knechtli

Haematology 03355882


  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Bupa Platinum consultant
Fee assured
Open Referral network


  • Face-to-face consultations
  • Video and telephone consultations
  • Home chemotherapy

About me

I underwent general training in clinical & laboratory haematology in the West Midlands and the Bristol/Bath area. In the middle of this training, I spent a 3 year period as a Research Fellow developing the use of the polymerase chain reaction to amplify immunoglobulin and T cell receptor genes as a means of assessing minimal residual disease in the bone marrow of children with acute lymphoblastic leukaemia before and after allogeneic stem cell transplantation.
I spend much of my time treating patients with various forms of haematological cancer (i.e. acute leukaemia, lymphoma, Hodgkin's disease, chronic lymphocytic leukaemia and chronic myeloid leukaemia) but I also have a large practice seeing and advising patients on other general haematological conditions (including anaemia, low platelet counts, myeloproliferative disorders and myelodysplasia as well as common coagulation problems).
Since my appointment as a Consultant Haematologist in Bath in January 2000, I was appointed as Clinical Director for Oncology & Haematology at the Royal United Hospital, a post that I held for 10 years until October 2010.
I set up the Oncology & Haematology Clinical Governance Committee in March 2001 and led the group until November 2013 when I was appointed Clinical Governance Lead for the Division of Medicine. I resigned from this latter role in November 2018. However, I now have responsibility for maintaining effective review of patients who have died at the RUH in order to identify and disseminate any learning that may have arisen from the care that they were provided with.
I was elected Chairman of the Avon, Somerset & Wiltshire Cancer Services Haematology Site Specialist Group from December 2001 to July 2006 and still play an active role in the group.
I was a regular member of the South West Regional Cancer Drug Fund Panel from its inception in January 2011 to May 2013.
I am a member of the Panel of Examiners for the Royal College of Pathologists which is responsible for ensuring that trainees in haematology meet the minimum standards to act as a Consultant.

Areas of interest

Haematological Oncology (e.g. leukaemia, lymphoma); Myeloproliferative disorders (e.g. polycythaemia, myelofibrosis, essential thrombocythaemia); Myelodysplasia; Anaemia; Leucopenia; Thrombocytopenia; Thrombosis & anticoagulation

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0004

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)

    Bath Clinic (5-50)

  • X3570

    Therapeutic venesection - (1-5)

    Bath Clinic (1-5)

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)

    Bath Clinic (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.